Resilience of drug and substance users and care model: Lessons from the COVID-19 pandemic
Article Sidebar
Main Article Content
Abstract
The COVID-19 pandemic has significantly impacted the number and ratio of drug use and addictive substances worldwide. The age of drug and addictive substance use has increased. The pattern of drug use has risen dramatically, and access to treatment has become difficult. This article presents the impact of drug use and addictive substances during the COVID-19 pandemic, a resilience concept for drug use and addictive substances, care models for drug use and addictive substances, and nursing care for drug use and addictive substances during the COVID-19 pandemic. The model of care during the COVID-19 pandemic should incorporate all healthcare service sectors and multidisciplinary teams to provide effective care using a resilience approach and telehealth for drug use and addictive substances. The concept of drug use and addictive substances during the COVID-19 pandemic included 1) the drug use and addictive substances aspect using the resilience concept, 2) the treatment aspect using telehealth, and 3) the nursing aspect using continuous care. In addition, research and development to integrate a resilience concept and telehealth for addictive substances to respond to pandemics in the future. However, tele-nursing has limited reach to patients because of the ability of drug use and addictive substances. Therefore, the car model for the group should be developed for drug use and addictive substances to respond to pandemics in the future.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวิทยาลัยพยาบาลบรมราชชนนี จังหวัดนนทบุรี
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับวิทยาลัยพยาบาลบรมราชชนนี จังหวัดนนทบุรี และคณาจารย์ท่านอื่น ในวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
References
United Nations Office on Drug Crime (UNODC). World Drug Report 2020 [internet]. 2020 [cited 2023 Mar 1]; Available from: https://wdr.unodc.org/uploads/wdr2020 /documents/UNODC_WDR20_Banner.pdf.
Office of the Narcotics Control Board. Thailand narcotics control annual report 2020. Bangkok: Ministry of Justice; 2020.
Kinorn P, Kalayasili, R. Misuse of medical drugs. In: Kalayasili R, editor. Fact and Figure Illegal substance in Thailand 2017-2020. Songkla: center of alcohol studies; 2020.
American Psychiatric Association. APA dictionary of psychology. 2018 [cited 2023 Mar 1]. Available from: https://dictionary.ap a.org/addiction.
Kalayasiri R. Addiction & psychiatric complications. [internet]. 2018 [cited 2023 Mar1]; Available from: https://cads.in.th/ cads/content. (in Thai).
Department of Correction. Statistical report on correctional cases under the Narcotics Act nationwide. [Internet]. 2023 [cited 2023 Mar 1]; Available from: http://www.correct.go. th/rt103pdf/report_ index.php?report=drug.
Research Centre for Social and Business Development. Survey of risk perception and addictive behavior during the COVID-19 pandemic. [Internet]. 2020 [cited 2023 Mar 1]; Available from: https://cads.in.th/cads/c ontent?id=111. (in Thai).
Thewjitcharoen Y, Krittiyawong S, Nakasatien S, Himathongkam T. Kratom-associated mixed cholestatic-hepatocellular liver injury in a patient with long COVID: a case report. Clin Med Insights Case Rep. 2022;15:1-6. doi: 10.1177/1179547622113 2824.
Muller E, Hillemacher T, Muller CP. Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - a case report. Heliyon. 2021;7(5): e07039. doi: 10.101 6/j.heliyon.2021.e07039.
Rudzinski K, McDonough P, Gartner R, Strike C. Is there room for resilience? A scoping review and critique of substance use literature and its utilization of the concept of resilience. Subst Abuse Treat Prev Policy. 2017;12:1-35. doi: 10.1186/ s13011-017-0125-2.
American Psychological Association. Building your resilience. [Internet]. 2020 [cited 2023 Mar 11]; Available from: https://www.apa.org/topics/resilience/building-your-resilience.
Abbasi NUH, Muhammad S. State resilience and rate of recovery among addicts: moderating role of social skills. Front Psychiatry. 2022;13:1-8. doi: org/1 0.3389/fpsyt.2022.906935.
Fabelo-Roche JR, Iglesias-More S, Gomez-Garcia AM. Persons with substance abuse disorders and other addictions: coping with the COVID-19 pandemic. MEDICC Rev. 2021;23(2): 55-63. doi: 10.37757/MR2021V 23.N2.2.
Faculty of Law, Thammasat University. New narcotic drugs act: What did the public gain? Will drug abuse decrease [Internet]. 2021 [cited 2023 Mar 11]; Available from: https://www.law.tu.ac.th /seminar-summary-new-narcotic-drugs-act/. (in Thai).
Saingam D. Substance abuse policy in Thailand: current challenges and future strategies. Journal of Drug and Alcohol Research. 2018;7(1):1-10. doi: 10.4303 /JDAR/236058.
Chitov A. The concept of drug offenses in Thai criminal justice. Thammasat Law Journal. 2023;52(1):150-76.
Morse SC, Fockele C, Huynh LN. Zatzick A, Whiteside LK. A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies. J Emerg Med. 2023;16:1-10. doi: org/10.1186/s12245-023-00505-0.
Clair K, Ijadi-Maghsoodi R, Nazinyan M, Gabrielian S, Kalofonos I. Veteran perspectives on adaptations to a VA residential rehabilitation program for substance use disorders during the novel Coronavirus pandemic. Community Ment Health J. 2021;57(5):801-7.
Sadicario JS, Parlier-Ahmad AB, Brechbiel JK, Islam LZ, Martin CE. Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program. J Subst Abuse Treat. 2021;122:1-4. doi.org/10.1016/j.jsat.2020.108200.
Substance Abuse and Mental Health Service Administration (SAMHSA). Adaptations and innovations for delivering mental health and substance use disorder treatment services during the COVID-19 pandemic. [Internet]. 2020 [cited 2023 Mar 1]; Available from: https://www.samhsa.gov/sites/default/files/dtac-adaptations-innovations-covid-19-pandemic.pdf.
Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Ann Intern Med. 2018;169 (3),137–45. doi: org/10.7 326/M17-3107.
Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622. doi: org/10.1001/ja manetworkopen.2019.20622.
Costa M, Reis G, Pavlo A, Bellamy C, Ponte K, Davidson L. Tele-mental health utilization among people with mental illness to access care during the COVID-19 pandemic. Community Ment Health J. 2021;57(4):720-26.
Clark L, Fan M, Stahlman S. Surveillance of mental and behavioral health care utilization and use of telehealth, active component, U.S. Armed Forces, MSMR. 2021;28(8):22–7.
Sorkin DH, Janio EA, Eikey EV, Schneider M, Davis K, Schueller SM, et al. Rise in use of digital mental health tools and technologies in the United States during the COVID-19 pandemic: Survey study. J Med Internet Res. 2021;23(4). doi: org/10.2196/269 94.
Liese BS, Monley CM. Providing addiction services during a pandemic: Lessons learned from COVID-19. J Subst Abuse Treat. 2021;120:1-4.
